Report Highlights
-
The U.S. medical plastics market is expected to reach almost 3.5 billion pounds by the end of 2010 and will grow at a compound annual growth rate (CAGR) of about 5%, consuming about 4.4 billion pounds by 2015.
-
Commodity thermoplastics dominate the market with a little more than 55% of total volume. This sector is estimated at nearly 2 billion pounds in 2010 and should increase at a compound annual growth rate (CAGR) of 4.8% to reach 2.5 billion pounds in 2015.
-
TPEs, engineering resins, and thermosets will show the most significant growth rates over the next 5 years although they only constitute about 20% of total volume. Of these, TPEs will experience the highest compound annual growth rate (CAGR) of 6.2%, from 68 million pounds in 2010 to 92 million pounds in 2015.
INTRODUCTION
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
Report Highlights
-
The U.S. medical plastics market will reach almost 2.7 billion pounds by the end of 2006 and will grow at an average annual growth rate (AAGR) of 4.4%, consuming over 3.3 billion pounds by 2011.
-
Commodity thermoplastics dominate the market with a little over 50% of total volume. This sector of the market should consume 1.7 billion pounds by the end of 2011, an AAGR of 4.2%.
-
TPEs represent the highest growth rate through the forecast period. In 2006, 137 million pounds were consumed. By the end of 2011, consumption will reach 181 million pounds, a 5.7% AAGR.
Report Highlights
-
The medical plastics market will rise at an average annual growth rate (AAGR) of 4.3% through 2008, from 2.2 billion pounds in 2002 to almost 2.9 billion pounds.
-
Disposable medical devices comprise about 60% of the total application volume.
-
Commodity thermoplastics represent just 50% of total product volume.
-
A slight shift to engineering resins, styrenics, thermosets and TPEs is forecast at the expense of commodity thermoplastics.
Report Highlights
-
The medical plastics market will reach almost 1.98 billion pounds by the end of 1999 and will grow at an annual rate of about 6%, consuming more than 2.6 billion pounds by 2004. Nondisposables comprise slightly more than 50% of total volume.
-
Commodity thermoplastics dominate the market with a little under 50% of total volume.
-
The Engineering resins market will grow at an annual rate of about 6.5%, consuming more than 0.3 billion pounds by 2004.
Related Reports
Recent Reports
Global Markets for Plastics Additives
The global market for plastics additives reached $58.9 billion in 2023. The market is expected to grow from $61.5 billion in 2024 to $80.7 billion by 2029, at a compound annual growth rate (CAGR) of 5.6% from 2024 through 2029.
Sustainable Packaging: Global Markets
The global market for sustainable packaging is estimated to increase from $278.1 billion in 2023 to reach $391.1 billion by 2029, at a compound annual growth rate (CAGR) of 6.0% from 2024 through 2029.
Sustainable Plastic Packaging: Global Markets
The global market for sustainable plastic packaging was valued at $81.6 billion in 2023. The market is expected to grow from $86.6 billion in 2024 to $122.4 billion by the end of 2029, at a compound annual growth rate, or CAGR, of 7.2% from 2024 to 2029.
Recycled Plastics in Construction Market
This report offers a qualitative as well as quantitative analysis of recycled plastics in the construction market. The quantitative analysis includes market estimates and forecasts and is applicable only to buildings. However, it includes trends pertaining to the global construction sector.
Plastic Injection Molding: Global Markets and Technologies
The global market for plastic injection molding was valued at $191.0 billion in 2023. The market is estimated to grow from $192.7 billion in 2024 to $235.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More